Corbus Pharmaceuticals Holdings (CRBP) Preferred Stock Liabilities (2013)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Preferred Stock Liabilities of $1.1 million in Q4 2013.

Corbus Pharmaceuticals Holdings (CRBP) Preferred Stock Liabilities (2013) Analysis & Trends

Corbus Pharmaceuticals Holdings' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $1.1 million for Q4 2013.

In Q4 2013, Preferred Stock Liabilities changed N/A year-over-year to $1.1 million; the TTM figure through Dec 2013 stood at $1.1 million (changed N/A YoY), while the FY2013 annual figure was $1.1 million, changed N/A from the prior year.
Preferred Stock Liabilities was $1.1 million for Q4 2013 at Corbus Pharmaceuticals Holdings.
In the past five years, Preferred Stock Liabilities ranged from a high of $1.1 million in Q4 2013 to a low of $1.1 million in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Corbus Pharmaceuticals Holdings	136.49 Mn	108.68 Mn	-	-

Download Data

Date	Value
Dec 31, 2013	1.11 Mn